Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus

Mika Hatano; Nobuyuki Yajima; Ryo Yanai; Sho Ishii; Yasushi Tsujimoto; Teruhisa Azuma; Tatsuya Atsumi; Yuko Kaneko; Hideto Kameda; Masataka Kuwana; Yoshiya Tanaka; Shiori Nakagawa; Ayako Nakajima; Yuri Hiramatsu; Daisuke Fujita; Takako Miyamae; Atsuko Murashima

doi:10.1093/mr/roae029

Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus

Mod Rheumatol. 2024 Apr 8:roae029. doi: 10.1093/mr/roae029. Online ahead of print.

Authors

Mika Hatano¹, Nobuyuki Yajima^{1

2

3}, Ryo Yanai¹, Sho Ishii¹, Yasushi Tsujimoto^{1

4

5

6}, Teruhisa Azuma⁷, Tatsuya Atsumi⁸, Yuko Kaneko⁹, Hideto Kameda¹⁰, Masataka Kuwana¹¹, Yoshiya Tanaka¹², Shiori Nakagawa¹³, Ayako Nakajima¹⁴, Yuri Hiramatsu¹⁵, Daisuke Fujita¹⁶, Takako Miyamae¹⁷, Atsuko Murashima¹⁸

Affiliations

¹ Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
² Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan.
³ Department of Clinical Epidemiology, Fukushima Medical University, Fukushima City, Fukushima, Japan; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima, Japan.
⁴ Oku medical clinic, Osaka, Japan.
⁵ Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto University, Kyoto, Japan.
⁶ Scientific Research WorkS Peer Support Group (SRWS-PSG), Osaka, Japan.
⁷ Department of General Medicine, Nara Prefecture General Medical Center, Nara, Japan.
⁸ Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
⁹ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
¹⁰ Division of Rheumatology, Toho University, Tokyo, Japan.
¹¹ Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan.
¹² First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
¹³ Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
¹⁴ Center for Rheumatic Diseases, Mie University Hospital, Mie, Japan.
¹⁵ Department of Internal Medicine IV, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
¹⁶ Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
¹⁷ Pediatric Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
¹⁸ Japan Drug Information Institute in Pregnancy National Center for Child Health and Development, Tokyo, Japan.

PMID: 38590037
DOI: 10.1093/mr/roae029

Abstract

Objectives: A quality indicator for the treatment of systemic lupus erythematosus during pregnancy and childbirth that is useful for sharing standard treatment policies has not yet been developed. This study aimed to develop a quality indicator for systemic lupus erythematosus associated with pregnancy and childbirth.

Methods: To identify candidate quality indicators, we conducted a systematic literature review on the development of quality indicators for systemic lupus erythematosus related to pregnancy and childbirth and on clinical practice guidelines. Candidate quality indicator items were extracted from the final selected articles, and a first evaluation, panel meeting, and second evaluation were conducted to determine whether the candidate items were appropriate as quality indicators. Items for which all panel members reached a consensus were designated pregnancy and childbirth-related systemic lupus erythematosus quality indicators.

Results: Four articles on systemic lupus erythematosus-quality indicator development and 28 practice guidelines were listed through abstract/text screening. Based on these studies, 52 candidate quality indicators were extracted that were limited to items related to pregnancy and childbirth, and 41 items were selected on which all panel members agreed.

Conclusion: We developed pregnancy-related systemic lupus erythematosus quality indicators using the RAND/UCLA method and selected 41 items, which could be used clinically.

Keywords: Childbirth; Pregnancy; Quality Indicators; Quality measures; Systemic lupus erythematosus.

© Japan College of Rheumatology 2024. Published by Oxford University Press. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site–for further information please contact journals.permissions@oup.com.